Butyryl chloride → N-Cyclopropyl-4-oxazol-5-yl-N-[1-(5-propyl-[1,2,4]oxadiazol-3-yl)-piperidin-4-yl]-benzamide

HRID 68855Notes

Reaction equation

HRID 68855 reaction equation
[CH:1]1([N:4]([CH:18]2[CH2:23][CH2:22][N:21]([C:24](=[NH:27])[NH:25][OH:26])[CH2:20][CH2:19]2)[C:5](=[O:17])[C:6]2[CH:11]=[CH:10][C:9]([C:12]3[O:16][CH:15]=[N:14][CH:13]=3)=[CH:8][CH:7]=2)[CH2:3][CH2:2]1.[C:28](Cl)(=O)[CH2:29][CH2:30][CH3:31]>>[CH:1]1([N:4]([CH:18]2[CH2:23][CH2:22][N:21]([C:24]3[N:27]=[C:28]([CH2:29][CH2:30][CH3:31])[O:26][N:25]=3)[CH2:20][CH2:19]2)[C:5](=[O:17])[C:6]2[CH:11]=[CH:10][C:9]([C:12]3[O:16][CH:15]=[N:14][CH:13]=3)=[CH:8][CH:7]=2)[CH2:3][CH2:2]1

Participants

3

Procedure

The title compound is prepared from N-cyclopropyl-N-[1-(N-hydroxycarbamimidoyl)-piperidin-4-yl]-4-oxazol-5-yl-benzamide and butyryl chloride following a procedure analogous to that described in Example 47. LC (method 8): tR=1.33 min; Mass spectrum (ESI+): m/z=422 [M+H]+.

Sources & evidence

ORD record
ord-e36fb9c4ce6449f8a435d1417be1b0ac
Source dataset
uspto-grants-2014_09
Patent number
US08822471B2

Reaction notes

Loading…